NYLI Healthy Hearts ETF HART

Medalist Rating as of | See New York Life Investment Hub

Morningstar’s Analysis HART

Will HART outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin IQ Healthy Hearts ETF's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HART

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 48.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Pfizer Inc

5.05 458,132
Healthcare

Alphabet Inc Class A

5.04 456,946
Communication Services

Abbott Laboratories

5.03 456,556
Healthcare

Apple Inc

5.02 455,723
Technology

UnitedHealth Group Inc

4.92 446,627
Healthcare

Johnson & Johnson

4.92 446,405
Healthcare

Novartis AG Registered Shares

4.85 440,322
Healthcare

Eli Lilly and Co

4.79 434,655
Healthcare

AstraZeneca PLC

4.55 412,975
Healthcare

Novo Nordisk AS Class B

4.54 411,903
Healthcare

Sponsor Center